• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CHA2DS2-VASC 评分与急性 ST 段抬高型心肌梗死患者住院期间心血管不良事件的相关性研究。

Association of CHA2DS2-VASC Score with in-Hospital Cardiovascular Adverse Events in Patients with Acute ST-Segment Elevation Myocardial Infarction.

机构信息

Department of Cardiology, The Second People's Hospital of Hefei, Hefei Hospital Affiliated to Anhui Medical University, Hefei 230011, Anhui, China.

Hefei Second People's Hospital Affiliated to Bengbu Medical College, Department of Cardiology, Hefei 230011, Anhui, China.

出版信息

Int J Clin Pract. 2022 Sep 23;2022:3659381. doi: 10.1155/2022/3659381. eCollection 2022.

DOI:10.1155/2022/3659381
PMID:36225534
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9525758/
Abstract

BACKGROUND

Acute ST-elevation myocardial infarction (STEMI) is a common clinical critical illness, and accurate, reliable, simple, and easy-to-remember tools are needed in clinical practice to quickly identify the risk of this condition in STEMI patients. This study investigates the predictive value of the admission CHA2DS2-VASc score for in-hospital MACE in STEMI patients.

METHODS

A total of 210 STEMI patients who visited the Chest Pain Center of the Second People's Hospital of Hefei from December 2019 to December 2021 were retrospectively analyzed. They were divided into MACE and non-MACE groups. The receiver operating characteristic curve (ROC) was used to assess the predictive value of the CHA2DS2-VASc score for MACE events during hospitalization.

RESULTS

The CHA2DS2-VASc score was higher in the MACE group than in the non-MACE group ( < 0.05), and multivariate logistic regression analysis showed that the CHA2DS2-VASc score was an independent risk factor for MACE events during hospitalization in STEMI patients (OR = 1.391, 95%CI 1.044-1.853, =0.024); ROC curve analysis showed that the area under the curve (AUC) of the CHA2DS2-VASc score was 0.744, the sensitivity was 0.64, the specificity was 0.694, and the optimal cutoff value was 3.5 in predicting the risk of MACE events during hospitalization in STEMI patients. There were no significant differences between the GRACE score (0.744 VS.0.827) and TIMI score (0.744VS.0.745) ( > 0.05).

CONCLUSION

The CHA2DS2-VASc score can successfully predict the occurrence of in-hospital MACE events in STEMI patients.

摘要

背景

急性 ST 段抬高型心肌梗死(STEMI)是一种常见的临床急危重症,临床工作中需要准确、可靠、简便、易记的工具来快速识别 STEMI 患者的发病风险。本研究旨在探讨入院时 CHA2DS2-VASc 评分对 STEMI 患者住院期间发生主要不良心血管事件(MACE)的预测价值。

方法

回顾性分析 2019 年 12 月至 2021 年 12 月在合肥市第二人民医院胸痛中心就诊的 210 例 STEMI 患者,根据住院期间是否发生 MACE 将其分为 MACE 组和非 MACE 组。采用受试者工作特征曲线(ROC)评估 CHA2DS2-VASc 评分对 STEMI 患者住院期间 MACE 事件的预测价值。

结果

MACE 组患者的 CHA2DS2-VASc 评分高于非 MACE 组( < 0.05),多因素 logistic 回归分析显示,CHA2DS2-VASc 评分是 STEMI 患者住院期间发生 MACE 事件的独立危险因素(OR=1.391,95%CI 1.044~1.853, =0.024);ROC 曲线分析显示,CHA2DS2-VASc 评分预测 STEMI 患者住院期间发生 MACE 事件的曲线下面积(AUC)为 0.744,敏感度为 0.64,特异度为 0.694,最佳截断值为 3.5;CHA2DS2-VASc 评分预测 STEMI 患者住院期间发生 MACE 事件的效能与 GRACE 评分(0.744 VS.0.827)和 TIMI 评分(0.744 VS.0.745)比较差异均无统计学意义( > 0.05)。

结论

CHA2DS2-VASc 评分可成功预测 STEMI 患者住院期间发生 MACE 事件。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6bf2/9525758/72dd7c55cc62/IJCLP2022-3659381.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6bf2/9525758/72dd7c55cc62/IJCLP2022-3659381.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6bf2/9525758/72dd7c55cc62/IJCLP2022-3659381.001.jpg

相似文献

1
Association of CHA2DS2-VASC Score with in-Hospital Cardiovascular Adverse Events in Patients with Acute ST-Segment Elevation Myocardial Infarction.CHA2DS2-VASC 评分与急性 ST 段抬高型心肌梗死患者住院期间心血管不良事件的相关性研究。
Int J Clin Pract. 2022 Sep 23;2022:3659381. doi: 10.1155/2022/3659381. eCollection 2022.
2
Predictive value of CHA DS -VASc score for in-hospital prognosis of patients with acute ST-segment elevation myocardial infarction undergoing primary PCI.CHA2DS2-VASc 评分对行直接经皮冠状动脉介入治疗的急性 ST 段抬高型心肌梗死患者住院期间预后的预测价值。
Clin Cardiol. 2023 Aug;46(8):950-957. doi: 10.1002/clc.24071. Epub 2023 Jul 10.
3
Risk evaluation of new-onset atrial fibrillation complicating ST-segment elevation myocardial infarction: a comparison between GRACE and CHADS-VASc scores.新发 ST 段抬高型心肌梗死合并心房颤动的风险评估:GRACE 评分与 CHADS-VASc 评分的比较。
Clin Interv Aging. 2018 Jun 6;13:1099-1109. doi: 10.2147/CIA.S166100. eCollection 2018.
4
Predictive value of CHADS and CHADS-VASc scores for coronary artery lesions and in-hospital prognosis of patients with acute ST-segment elevation myocardial infarction.CHADS 和 CHADS-VASc 评分对急性 ST 段抬高型心肌梗死患者冠状动脉病变及院内预后的预测价值。
BMC Cardiovasc Disord. 2021 Sep 15;21(1):439. doi: 10.1186/s12872-021-02257-2.
5
Usefulness of the CHADS-VASc Score to Predict Adverse Outcomes in Acute Coronary Syndrome Patients Without Atrial Fibrillation Undergoing Percutaneous Coronary Intervention.CHADS-VASc 评分在经皮冠状动脉介入治疗的无房颤急性冠状动脉综合征患者中预测不良结局的价值。
Am J Cardiol. 2019 Aug 15;124(4):476-484. doi: 10.1016/j.amjcard.2019.05.036. Epub 2019 May 29.
6
CHA2DS2-VASc-HS score in non-ST elevation acute coronary syndrome patients: assessment of coronary artery disease severity and complexity and comparison to other scoring systems in the prediction of in-hospital major adverse cardiovascular events.非ST段抬高型急性冠状动脉综合征患者的CHA2DS2-VASc-HS评分:评估冠状动脉疾病的严重程度和复杂性,并与其他评分系统比较以预测院内主要不良心血管事件
Anatol J Cardiol. 2016 Oct;16(10):742-748. doi: 10.14744/AnatolJCardiol.2015.6593. Epub 2016 Mar 23.
7
Predictive value of triglyceride glucose index combined with neutrophil-to-lymphocyte ratio for major adverse cardiac events after PCI for acute ST-segment elevation myocardial infarction.三酰甘油葡萄糖指数联合中性粒细胞与淋巴细胞比值对急性 ST 段抬高型心肌梗死患者经皮冠状动脉介入治疗后主要不良心脏事件的预测价值。
Sci Rep. 2024 Jun 2;14(1):12634. doi: 10.1038/s41598-024-63604-9.
8
[The predictive value of the CHADS-VASc score for in-hospital outcomes in patients with acute myocardial infarction: China PEACE-retrospective acute myocardial infarction study].[CHADS-VASc评分对急性心肌梗死患者院内结局的预测价值:中国PEACE-急性心肌梗死回顾性研究]
Zhonghua Nei Ke Za Zhi. 2022 Feb 1;61(2):177-184. doi: 10.3760/cma.j.cn112138-20210913-00634.
9
The Predictive Value of CHA2DS2-VASc Score on Residual Syntax Score in Patients With ST Segment Elevation Myocardial Infarction.CHA2DS2-VASc 评分对 ST 段抬高型心肌梗死患者残余Syntax 评分的预测价值。
Arq Bras Cardiol. 2022 Sep;119(3):393-399. doi: 10.36660/abc.20210670.
10
The CHA2DS2-VASc score for predicting atrial fibrillation in patients presenting with ST elevation myocardial infarction: prospective observational study.CHA2DS2-VASc评分预测ST段抬高型心肌梗死患者房颤发生情况:前瞻性观察研究
Sao Paulo Med J. 2019 Jul 22;137(3):248-254. doi: 10.1590/1516-3180.2018.0431140319.

引用本文的文献

1
Hemoglobin, albumin, lymphocyte, and platelet (HALP) score predict prognosis in patients with atrial fibrillation and acute coronary syndrome or undergoing percutaneous coronary intervention.血红蛋白、白蛋白、淋巴细胞和血小板(HALP)评分可预测心房颤动合并急性冠状动脉综合征患者或接受经皮冠状动脉介入治疗患者的预后。
BMC Cardiovasc Disord. 2025 Jul 14;25(1):507. doi: 10.1186/s12872-025-04968-2.
2
Predictive value of CHA DS -VASc score for in-hospital prognosis of patients with acute ST-segment elevation myocardial infarction undergoing primary PCI.CHA2DS2-VASc 评分对行直接经皮冠状动脉介入治疗的急性 ST 段抬高型心肌梗死患者住院期间预后的预测价值。
Clin Cardiol. 2023 Aug;46(8):950-957. doi: 10.1002/clc.24071. Epub 2023 Jul 10.

本文引用的文献

1
The Value of Serum YKL-40 and TNF- in the Diagnosis of Acute ST-Segment Elevation Myocardial Infarction.血清YKL-40和肿瘤坏死因子在急性ST段抬高型心肌梗死诊断中的价值
Cardiol Res Pract. 2022 Aug 23;2022:4905954. doi: 10.1155/2022/4905954. eCollection 2022.
2
Assessment of the CHADS-VASc Score for the Prediction of Death in Elderly Patients With Coronary Artery Disease and Atrial Fibrillation.评估CHADS-VASc评分对老年冠心病合并心房颤动患者死亡的预测价值。
Front Cardiovasc Med. 2021 Dec 24;8:805234. doi: 10.3389/fcvm.2021.805234. eCollection 2021.
3
CHA2DS2-VASc Score for Major Adverse Cardiovascular Events Stratification in Patients with Pneumonia with and without Atrial Fibrillation.
用于有和无房颤的肺炎患者主要不良心血管事件分层的CHA2DS2-VASc评分
J Clin Med. 2021 Sep 10;10(18):4093. doi: 10.3390/jcm10184093.
4
Predictive value of CHADS and CHADS-VASc scores for coronary artery lesions and in-hospital prognosis of patients with acute ST-segment elevation myocardial infarction.CHADS 和 CHADS-VASc 评分对急性 ST 段抬高型心肌梗死患者冠状动脉病变及院内预后的预测价值。
BMC Cardiovasc Disord. 2021 Sep 15;21(1):439. doi: 10.1186/s12872-021-02257-2.
5
The CHA2DS2-VASc Score and Its Association with Long-Term Outcome in a Cardiac Resynchronization Therapy Population.CHA2DS2-VASc 评分与心脏再同步治疗人群的长期预后的关系。
Cardiology. 2021;146(4):453-463. doi: 10.1159/000513955. Epub 2021 May 7.
6
Higher serum level of Cystatin C: An additional risk factor of CAD.血清胱抑素 C 水平升高:CAD 的附加危险因素。
Medicine (Baltimore). 2021 Jan 15;100(2):e24269. doi: 10.1097/MD.0000000000024269.
7
The Predictive Value of CHADS-VASc Score on In-Hospital Death and Adverse Periprocedural Events Among Patients With the Acute Coronary Syndrome and Atrial Fibrillation Who Undergo Percutaneous Coronary Intervention: A 10-Year National Inpatient Sample (NIS) Analysis.CHADS-VASc评分对接受经皮冠状动脉介入治疗的急性冠状动脉综合征合并心房颤动患者住院死亡及围手术期不良事件的预测价值:一项为期10年的全国住院患者样本(NIS)分析
Cardiovasc Revasc Med. 2021 Aug;29:61-68. doi: 10.1016/j.carrev.2020.08.003. Epub 2020 Aug 7.
8
CHA2DS2-VASc and ATRIA Scores and Clinical Outcomes in Patients with Heart Failure with Preserved Ejection Fraction.CHA2DS2-VASc 和 ATRIA 评分与射血分数保留的心力衰竭患者的临床结局。
Cardiovasc Drugs Ther. 2020 Dec;34(6):763-772. doi: 10.1007/s10557-020-07011-y.
9
CHA2DS2-VASc score performance to predict stroke after acute decompensated heart failure with and without reduced ejection fraction.CHA2DS2-VASc 评分对射血分数降低和不降低的急性失代偿性心力衰竭后卒中的预测作用。
Europace. 2019 Nov 1;21(11):1639-1645. doi: 10.1093/europace/euz192.
10
Usefulness of the CHADS-VASc Score to Predict Adverse Outcomes in Acute Coronary Syndrome Patients Without Atrial Fibrillation Undergoing Percutaneous Coronary Intervention.CHADS-VASc 评分在经皮冠状动脉介入治疗的无房颤急性冠状动脉综合征患者中预测不良结局的价值。
Am J Cardiol. 2019 Aug 15;124(4):476-484. doi: 10.1016/j.amjcard.2019.05.036. Epub 2019 May 29.